Retinal S-antigen Th1 cell epitope mapping in patients with Behcet's disease

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 4, 2009, Pages 555-560

  Zhao, Changlin ^a,b   Yang, Peizeng ^a,c   He, Hao ^a   Lin, Xiaomin ^a   Du, Liping ^a   Zhou, Hongyan ^a   Kijlstra, Aize ^d,e  

^a SUN YAT SEN UNIVERSITY   (China)

^b Nanjing Liberation Army 81 Hospital   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Behcet's disease; Epitope mapping; Retinal Santigen; Uveitis

Indexed keywords

GAMMA INTERFERON; PEPTIDE DERIVATIVE; PROTEIN P31; PROTEIN P35; PROTEIN P40; RETINA S ANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; ARTICLE; BEHCET DISEASE; BLOOD ANALYSIS; CELL ISOLATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PEPTIDE ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TH1 CELL;

ADULT; AMINO ACID SEQUENCE; ARRESTIN; AUTOANTIGENS; BEHCET SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMANS; IMMUNITY, CELLULAR; IMMUNODOMINANT EPITOPES; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; TH1 CELLS;

EID: 62149104800     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0970-9     Document Type: Article

References (23)

1. Murphy CC, Duncan L, Forrester JV, Dick AD (2004) Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis. Br J Ophthalmol 88:412-416. doi: 10.1136/bjo.2003.028506
2. Nussenblatt RB, Kuwabara T, de Monasterio FM, Wacker WB (1981) S-antigen uveitis in primates. A new model for human disease. Arch Ophthalmol 99:1090-1092
3. Torseth JW, Gregerson DS (1998) Oral tolerance in experimental autoimmune uveoretinitis: Feeding after disease induction is less protective than prefeeding. Clin Immunol Immunopathol 88:297-304. doi: 10.1006/clin.1998.4592
4. Liang W, Karabekian Z, Mattapallil M, Xu Q, Viley AM, Caspi R et al (2006) B-cell delivered gene transfer of human S-Ag-Ig fusion protein protects from experimental autoimmune uveitis. Clin Immunol 118:35-41. doi: 10.1016/j.clim.2005.08.007
5. Vanderlugt CL, Miller SD (2002) Epitope spreading in immune-mediated diseases: Implications for immunotherapy. Nat Rev Immunol 2:85-95. doi: 10.1038/nri724
6. de Smet MD, Bitar G, Mainigi S, Nussenblatt RB (2001) Human S-antigen determinant recognition in uveitis. Invest Ophthalmol Vis Sci 42:3233-3238
7. Rai G, Saxena S, Kumar H, Singh VK (2001) Human retinal S-antigen: T cell epitope mapping in posterior uveitis patients. Exp Mol Pathol 70:140-145. doi: 10.1006/exmp.2000.2338
8. Tripathi P, Saxena S, Yadav VS, Naik S, Singh VK (2004) Human S-antigen: peptide determinant recognition in uveitis patients. Exp Mol Pathol 76:122-128. doi: 10.1016/j.yexmp.2003.10.007
9. Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y et al (2005) Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 30:943-948. doi: 10.1080/02713680500263606
10. Yamamoto JH, Minami M, Inaba G, Masuda K, Mochizuki M (1993) Cellular autoimmunity to retinal specific antigens in patients with Behcet's disease. Br J Ophthalmol 77:584-589. doi: 10.1136/bjo.77.9.584
11. International Study Group for Behcet's Disease (1990) Criteria for diagnosis of Behcet's disease. Lancet 335:1078-1080
12. Zhao C, Yang P, He H, Lin X, Li B, Zhou H et al (2008) S -antigen specific T helper type 1 response is present in Behcet's disease. Mol Vis 14:1456-1464
13. Baricordi OR, Sensi A, Pivetti-Pezzi P, Perrone S, Balboni A, Catarinelli G et al (1986) Behcet's disease associated with HLA-B51 and DRw52 antigens in Italians. Hum Immunol 17:297-301. doi: 10.1016/ 0198-8859(86)90281-8
14. Chang HK, Kim JU, Cheon KS, Chung HR, Lee KW, Lee IH (2001) HLA-B51 and its allelic types in association with Behcet's disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol 19:S31-S35
15. Guerkov RE, Targoni OS, Kreher CR, Boehm BO, Herrera MT, Tary-Lehmann M et al (2003) Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: Cognate vs. nonspecific production of the cytokine. J Immunol Methods 279:111-121. doi: 10.1016/ S0022-1759(03)00240-0
16. Nagata M, Moriyama H, Kotani R, Yasuda H, Kishi M, Kurohara M et al (2007) Immunological aspects of 'fulminant type 1 diabetes'. Diabetes Res Clin Pract 77:S99-S103. doi: 10.1016/j.diabres.2007.01.041
17. Van der Aa A, Hellings N, Bernard CC, Raus J, Stinissen P (2003) Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls. J Neuroimmunol 137:164-176. doi: 10.1016/S0165-5728(03)00048-1
18. Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M (1998) Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behcet's disease. Invest Ophthalmol Vis Sci 39:996-1004
19. de Smet MD, Bitar G, Roberge FG, Gery I, Nussenblatt RB (1993) Human S-antigen: Presence of multiple immunogenic and immunopathogenic sites in the Lewis rat. J Autoimmun 6:587-599. doi: 10.1006/jaut.1993.1048
20. Prendergast RA, Iliff CE, Coskuncan NM, Caspi RR, Sartani G, Tarrant TK et al (1998) T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 39:754-762
21. Vanderlugt CL, Begolka WS, Neville KL, Katz-Levy Y, Howard LM, Eagar TN et al (1998) The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol Rev 164:63-72. doi: 10.1111/j.1600-065X.1998.tb01208.x
22. Deeg CA, Amann B, Raith AJ, Kaspers B (2006) Inter- and intramolecular epitope spreading in equine recurrent uveitis. Invest Ophthalmol Vis Sci 47:652-656. doi: 10.1167/iovs.05-0789
23. Mazzanti B, Hemmer B, Traggiai E, Ballerini C, McFarland HF, Massacesi L et al (2000) Decrypting the spectrum of antigen-specific T-cell responses: The avidity repertoire of MBP-specific T-cells. J Neurosci Res 59:86-93. doi: 10.1002/ (SICI)1097-4547(20000101)59:1<86::AID-JNR10>3.0.CO;2-U